Tilray | TRLY - 税前利润

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.63B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	税前利润	更改		日
Acasti Pharma	USD -2.31M		1.38M	2025-12
Akebia Therapeutics	USD -11.24M		12.39M	2025-12
Alaunos Therapeutics	USD -7.84M		633K	2023-12
Aurora Cannabis	CAD -1.58M		48.55M	2025-12
Avita Medical	AUD -11.64M		12.13M	2025-12
Canopy Growth	CAD -62.26M		60.84M	2025-12
Cronos Group	USD -12.39M		44.16M	2025-12
Dianthus Therapeutics	USD -64.43M		27.67M	2025-12
Divis Laboratories Ltd	INR 8.54B		580M	2025-12
Ionis Pharmaceuticals	USD -93M		135M	2026-03
IQVIA Holdings	USD 6.22B		5.68B	2026-03
Knight Therapeutics	CAD -1.92M		13.69M	2025-09
Moderna	USD -799M		612M	2025-12
Organigram Holdings	CAD -41.72M		25.52M	2025-09
Organon & Co	USD -148M		391M	2025-12
Revvity	USD 91.56M		35.88M	2025-12
Tectonic Therapeutic	USD -18.97M		63K	2025-12
Tilray	USD -39.96M		39.19M	2025-09
Viatris	USD -343M		335.1M	2025-12
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12
Zealand Pharma A/S	-406.5M		39.77M	2025-12